Table 3 Association between participant characteristics and baseline MDRO colonization or new MDRO acquisitions
Characteristic | Unadjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value |
|---|---|---|---|---|
MDRO Colonization at Baseline (N = 188)a | ||||
Recent Antibiotic Use | ||||
No (59) | 1 [Reference] | 1 [Reference] | ||
Yes (129) | 3.45 (1.65-7.25) | <0.001 | 3.45 (1.53-7.81) | 0.003 |
Wounds at Baseline | ||||
No (124) | 1 [Reference] | 1 [Reference] | ||
Yes (64) | 2.00 (1.07-3.72) | 0.029 | 1.51 (0.75-3.04) | 0.243 |
Katz (ADL) Score (188) | 1.13 (0.98-1.31) | 0.098 | 1.18 (0.99-1.39) | 0.051 |
Preadmission Hospitalization Stay | ||||
≤14 Days (142) | 1 [Reference] | 1 [Reference] | ||
>14 Days (46) | 3.09 (1.56-6.14) | 0.001 | 2.94 (1.42-6.07) | 0.004 |
NH Facility | ||||
Facility A (94) | 1 [Reference] | 1 [Reference] | ||
Facility B (55) | 1.43 (0.72-2.83) | 0.302 | 2.09 (0.94-4.61) | 0.069 |
Facility C (39) | 0.73 (0.32-1.64) | 0.442 | 0.82 (0.33-2.00) | 0.662 |
Any New MDRO Acquisition (N = 173)b | ||||
Length of Stay in Study (days) (173) | 1.02 (1.01-1.03) | 0.006 | 1.02 (1.01-1.03) | 0.006 |
NH Facility | ||||
Facility A (88) | 1 [Reference] | 1 [Reference] | ||
Facility B (51) | 1.37 (0.68-2.76) | 0.379 | 1.18 (0.57-2.43) | 0.661 |
Facility C (34) | 1.32 (0.59-2.34) | 0.503 | 1.47 (0.64-3.38) | 0.359 |
